Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med Scullard GH, Smith CI, Merigan TC, et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81:987-991. Hoofnagle JG, Dusheiko GM, Schafer DF, et al. Reactiva
Skin manifestation of agnogenic myeloid metaplasia
β Scribed by Gabriel Loewy; Anna Mathew; Ariel Distenfeld
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 449 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Agnogenlc myeloid metaplasla (AMN) with myeloflbrosis is a clonal malignancy of the hematopoletic stem cell. The disease is characterized by Increased endothelial cell and fibroblast proliferation, resulting in Increased deposition of flbronectln, lamlnln, and collagen in the bone marrow. In advanced disease, extramedullary hematopoiesis (EMH) is invariably seen In the spleen and liver. The lymph nodes are also frequent sites of EMH, but other organs, especially the kidneys, arenals, lungs, pleura, ovaries, gastrointestinal tract, and dura, may also be Involved. Skin manifestations are rare. They may present in several ways: erythematous plaques, nodules, diffuse or papular erythema, ulcers, and bullae. Histopathology of these lesions reveals cells from one or more myeloid lineage in the dermis, erythrold, or megakaryocytic series alone or In combination. In rare cases, all three cell lines are demonstrated. o iw W~IOY-USS, in^.
π SIMILAR VOLUMES
The case of a patient with agnogenic myeloid metaplasia and myelofibrosis engrafted upon a longstanding treated case of polycythemia rubra Vera and presenting with ascites due to peritoneal implants of myeloid tissue is presented. Comments on the differential diagnosis of ascites in general, and esp
Peripheral cytopenias are common in patients with agnogenic myeloid metaplasia (AMM). They are an important cause of morbidity and mortality, and their treatment is difficult. We report on 4 patients with AMM and severe cytopenia treated with danazol (400-600 mg/ day). Three of them became independe